Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,096.93
-1.4353-0.07%
Number of Gainers:531
Number of Losers:467
Number of Flat:23
PE:- -
High:2,101.76
Open:2,098.37
Low:2,094.77
Close:2,098.37
Volume:4.07B
Turnover:525.13B
Market Cap:97.54T
Float Cap:91.32T

Loading ...

Micron Stock Falls Amid Fears of Memory-Price Peak. the Data Tell a Different Story.

Dow Jones
·
Oct 05

GE Healthcare to Buy Sofie for Nearly $1 Billion to Grow Medical-Imaging Business- WSJ

THOMSON REUTERS
·
Oct 05

BridgeBio Says Phase 3 Fortify Data Show BBP-418 Normalizes HS Troponin I in Lgmd2i/r9 Patients by Month 12

Reuters
·
Oct 05

NFI Unit New Flyer Wins Washington Metro Order for 100 Buses

Reuters
·
Oct 05

Goldera Identifies Two New Parallel Structures at E1 Zone, Expands Egan Gold Target Area Ahead of Q4 Drilling

Reuters
·
Oct 05

Terra Clean Energy Hires KB Drilling for 10,000-Foot Core Program at Marysvale Uranium Project in Utah

Reuters
·
Oct 05

Nexus Advanced Technologies Sets $2.5 Million Note Repayment Under Restructuring Deal with Anson Funds

Reuters
·
Oct 05

Stardust Power Opens Houston Office to Support Muskogee Lithium Refinery Build

Reuters
·
Oct 05

Globaltech Forms Independent Audit, Compensation and Nominating Governance Board Committees

Reuters
·
Oct 05

Canadian Goldfields to Launch Property-Wide Airborne Magnetic Survey at Miminiska Gold Project in Ontario

Reuters
·
Oct 05

Bbp-418 Demonstrates Potential to be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels

THOMSON REUTERS
·
Oct 05

BridgeBio Pharma - Bbp-418 Met All Primary and Secondary Endpoints at 12-Month Interim Phase 3 Fortify Trial

THOMSON REUTERS
·
Oct 05

BridgeBio Pharma - 100% of Bbp-418-Treated Lgmd2i/R9 Patients Normalize Hs Troponin I at Month 12

THOMSON REUTERS
·
Oct 05

BridgeBio Pharma - Bbp-418 Under FDA Priority Review with Pdufa Date November 27, 2026

THOMSON REUTERS
·
Oct 05

Vireo Growth Buys Palatka, Florida Cultivation Facility in US$60 Million Real Estate Financing

Reuters
·
Oct 05

Krispy Kreme Updates Financial Calendar with Third-Quarter 2026 Results Release and Conference Call

Reuters
·
Oct 05

Ice - Freight Complex NOW Includes over 90 Contracts Across 30 Global Routes

THOMSON REUTERS
·
Oct 05

What Will Washington Do Next If US Bond Yields Keep Rising?

Reuters
·
Oct 05

C.H. Robinson to Buy RXO for About $5 Billion

Dow Jones
·
Oct 05

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

GlobeNewswire
·
Oct 05